NAI FOVINO, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 2.416
EU - Europa 590
AS - Asia 425
SA - Sud America 12
OC - Oceania 4
AF - Africa 2
Totale 3.449
Nazione #
US - Stati Uniti d'America 2.413
IT - Italia 354
CN - Cina 221
SG - Singapore 161
SE - Svezia 52
FR - Francia 42
FI - Finlandia 39
DE - Germania 33
GB - Regno Unito 31
IE - Irlanda 14
VN - Vietnam 13
BR - Brasile 8
HK - Hong Kong 8
IN - India 8
JP - Giappone 7
RU - Federazione Russa 7
UA - Ucraina 5
AU - Australia 3
BE - Belgio 3
CA - Canada 3
AR - Argentina 2
EG - Egitto 2
HU - Ungheria 2
NL - Olanda 2
TR - Turchia 2
TW - Taiwan 2
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
ES - Italia 1
GE - Georgia 1
GR - Grecia 1
ID - Indonesia 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PE - Perù 1
PL - Polonia 1
Totale 3.449
Città #
Fairfield 395
Chandler 233
Ashburn 203
Cambridge 198
Woodbridge 189
Seattle 151
Houston 130
Singapore 130
Wilmington 121
Ann Arbor 108
Padova 92
Boardman 79
Beijing 64
Santa Clara 61
Medford 51
Princeton 47
San Diego 45
Helsinki 35
Milan 35
Des Moines 31
Nanjing 15
Dong Ket 13
London 13
Dublin 11
Jinan 10
Rheinfelden 10
Ogden 9
Palermo 9
Rome 8
Hong Kong 7
Roxbury 7
Cagliari 6
Washington 6
Buffalo 5
Guangzhou 5
Ningbo 5
Shenyang 5
São Paulo 5
Boydton 4
Hebei 4
Los Angeles 4
New York 4
Treviso 4
Villorba 4
Barueri 3
Borås 3
Casamicciola Terme 3
Casier 3
Forlì 3
Genoa 3
Hasselt 3
Hefei 3
Lahr 3
Mortara 3
Munich 3
Nanchang 3
New Bedfont 3
Norwalk 3
Ospedaletto Euganeo 3
Portlaoise 3
Redmond 3
Salerno 3
Bollate 2
Changsha 2
Chicago 2
Cipolletti 2
Civitavecchia 2
Falkenstein 2
Forno 2
Haikou 2
Hangzhou 2
Iseo 2
Jiaxing 2
Kunming 2
Lappeenranta 2
L’Aquila 2
Mariano Comense 2
Mirano 2
Mussolente 2
Naples 2
Osaka 2
Portland 2
Prescot 2
Roswell 2
Shanghai 2
Strasbourg 2
Taipei 2
Taizhou 2
Toronto 2
Trieste 2
Urom 2
Wuppertal 2
Amsterdam 1
Arezzo 1
Auckland 1
Bergamo 1
Berlin 1
Cairo 1
Canberra 1
Catania 1
Totale 2.693
Nome #
A2-P3 oblique clipping for the treatment of severe mitral regurgitation in the presence of mitral valve cleft and flail 116
Anatomical Predictors of Pacemaker Dependency after Transcatheter Aortic Valve Replacement 115
Asymptomatic Severe Aortic Stenosis and Noncardiac Surgery 113
'Full-plastic jacket' with bioresorbable vascular scaffolds: 5-year optical coherence tomography follow-up 103
TAVR with mechanically expandable prostheses: Is balloon aortic valvuloplasty really necessary? 94
“Full-plastic jacket” with everolimus-eluting Absorb bioresorbable vascular scaffolds: Clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413) 89
Transcatheter aortic valve implantation in lower-risk patients: what is the perspective? 86
Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed by Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy 84
Real-World Experience With a Large Bore Vascular Closure Device During TAVI Procedure: Features and Predictors of Access-Site Vascular Complications 83
Unmasking Myocardial Bridge-Related Ischemia by Intracoronary Functional Evaluation 81
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis 81
Using wearable devices to monitor physical activity in patients undergoing aortic valve replacement: Protocol for a prospective observational study 79
Non-culprit coronary vasospasm in a woman affected by Churg-Strauss syndrome presenting with ST-elevation myocardial infarction 77
Transcatheter versus surgical aortic valve replacement in low- and intermediate-risk patients: an updated systematic review and meta-analysis 75
The impact of pre-existing peripheral artery disease on transcatheter aortic valve implantation outcomes: A systematic review and meta-analysis 75
Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the risk of coronary access impairment after tavr-in-tavr 75
Coronary Access and Percutaneous Coronary Intervention up to 3 Years after Transcatheter Aortic Valve Implantation with a Balloon-Expandable Valve 74
Timing of Oral P2Y12 Inhibitor Administration in Non-ST Elevation Acute Coronary Syndrome 74
Association between surgical risk and 30-day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis 74
The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis 71
Long-term outcomes and prosthesis performance after transcatheter aortic valve replacement: Results of self-expandable and balloon-expandable transcatheter heart valves 68
Percutaneous repair of ascending aorta pseudoaneurysm and aortopulmonary fistula with two Amplatzer septal occluder devices 66
Factors influencing the choice between transcatheter and surgical treatment of severe aortic stenosis in patients younger than 80 years: Results from the OBSERVANT study 65
Coronary Access After Transcatheter Aortic Valve Replacement in Patients With Bicuspid Aortic Valve: Lights and Shades 62
Left ventricular outflow tract rupture during transcatheter aortic valve implantation: anatomic evidence of the vulnerable area 61
Pulmonary artery rupture during right heart catheterization: Successful endovascular treatment with Amplatzer Vascular Plug 60
Incidence and feasibility of coronary access after transcatheter aortic valve replacement 60
Coronary access after transcatheter aortic valve replacement 60
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials 56
Transcatheter treatment of native aortic valve regurgitation: Results from an international registry using the transfemoral ACURATE neo valve 55
Transfemoral aortic valve implantation with new-generation devices: The repositionable Lotus vs. The balloon-expandable Edwards Sapien 3 valve 53
[Impact of COVID-19 pandemic on structural heart interventions in Italy] 52
Tavr-in-tavr and coronary access: Importance of preprocedural planning 51
Left main bifurcation PCI with the culotte technique using two self-apposing stents 51
Treatment of aortic stenosis in patients with chronic liver disease: Another win for transfemoral TAVR? 50
Coronary Access After Transcatheter Aortic Valve Replacement With Commissural Alignment: The ALIGN-ACCESS Study 50
Lifetime Strategy of Patients With Aortic Stenosis: The First Cut Is the Deepest 47
Preexisting diastolic dysfunction in patients undergoing TAVR matters—But what about diastole the day after TAVR? 44
Coronary Access and TAVR-in-TAVR: Don't Put Off Until Tomorrow What You Can Do Today 44
TAVR versus SAVR in patients with severe aortic stenosis and concomitant end stage liver disease: When less is more 38
High-risk percutaneous coronary intervention using hemodynamic support device eight years after transcatheter aortic valve implantation 38
The rescue snared wire technique for challenging transcatheter pulmonary valve implantation: A case series of two patients 37
10-Year Impact of Transcatheter Aortic Valve Replacement Leaflet Design (Intra- Versus Supra-Annular) in Mortality and Hemodynamic Performance 35
Subclinical coronary artery disease in COVID-19 patients 34
Impella ventricular assist device: A “valvular bypass” to support high-risk percutaneous coronary intervention or complicated transcatheter aortic valve replacement 33
Treatment of degenerated surgical aortic valve: The importance of having a "lifetime strategy" in younger patients with severe aortic disease 33
Institutional re-evolution of mitral valve procedures 32
Transcatheter aortic valve-in-valve implantation for the treatment of a failed surgical bioprosthesis of small size 32
Definition of trAnscatheter heart Valve orIeNtation in biCuspId aortic valve: The DA VINCI pilot study 31
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study 30
Impact of a 10 Rules Protocol on COVID-19 Hospital-Related Transmission: Insights from Padua University Hospital, Italy 30
Reducing vascular complications of large-bore sheaths removal with a novel post-closure technique: Adapt and evolve 29
Transcatheter Aortic Valve Replacement With Self-Expanding ACURATE neo2: Postprocedural Hemodynamic and Short-Term Clinical Outcomes 28
[Left main percutaneous coronary intervention using zotarolimus-eluting stent: data from the ROLEX registry] 26
Prevalence and Prognostic Impact of Carotid Artery Disease in Patients Undergoing TAVI 26
[Prosthesis embolization during transcatheter aortic valve implantation] 25
Risk stratification and prognostic assessment by gated Single Photon Emission Computed Tomography (SPECT) in patients with Left Bundle-Branch Block (LBBB). 25
Negative impact of coronavirus on interventional cardiology fellows' training: Let's limit collateral damage of the pandemic 25
Management and Outcome of Acute Ischemic Stroke Complicating Transcatheter Aortic Valve Replacement 23
Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves 22
Risk Stratification and Prognostic Assessment by Myocardial Perfusion gated single photon emission computed tomography (SPECT) in Patients with Left Bundle-Branch Block (LBBB) and Low-Intermediate Cardiac Risk 22
Diagnostic and Prognostic meaning of Gated Stress Cardiac Single-Photon Emission Computed Tomography Imaging (gated SPECT) in patients with Left Bundle-Brunch Block (LBBB) and without Coronary Artery Disease (CAD). 22
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery 18
Diagnostic and prognostic value of gated myocardial perfusion single-photon emission computed tomography in low-risk patients with left bundle-branch block 18
Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome 17
Association between surgical risk and 30-day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis 17
Transcatheter aortic valve replacement for structural degeneration of previously implanted transcatheter valves (TAVR-in-TAVR): a systematic review 14
Anatomical and pathophysiological considerations on the left main coronary artery 14
Coronary Access and Percutaneous Coronary Intervention Up to 3 Years After Transcatheter Aortic Valve Implantation With a Balloon-Expandable Valve 13
Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves 13
Coronary Angiography After Transcatheter Aortic Valve Replacement (TAVR) to Evaluate the Risk of Coronary Access Impairment After TAVR-in-TAVR 11
New-Onset Exertional Dyspnea in a Young Patient With Previous Blunt Chest Trauma 9
Prognostic value of myocardial perfusion scintigraphy in elderly patients with hypertension: a 10-year follow-up analysis 9
Impella ventricular assist device: A "valvular bypass" to support high-risk percutaneous coronary intervention or complicated transcatheter aortic valve replacement 8
Transcatheter treatment of native aortic valve regurgitation: Results from an international registry using the transfemoral ACURATE neo valve 7
DinoSAVR struck by the TAVR asteroids 1
Totale 3.619
Categoria #
all - tutte 18.518
article - articoli 17.709
book - libri 206
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.433


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020344 0 0 0 0 34 37 42 71 55 49 37 19
2020/2021611 8 23 66 61 83 54 25 57 79 48 62 45
2021/2022706 15 58 58 44 46 72 17 71 114 25 40 146
2022/2023739 94 37 26 73 78 53 10 29 44 20 34 241
2023/2024530 15 66 48 31 47 38 50 35 61 35 57 47
2024/2025421 13 139 78 52 139 0 0 0 0 0 0 0
Totale 3.619